실시간 바이오 인텔리전스 · ADC · CGT

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

8,428+프로그램
40+FDA 승인
3,743+모집 중
ADC 1032·Antibody 4683·CGT 2713차세대 추천 →·Data Tier →
8428프로그램40FDA 승인
2,790오늘 방문
13,430누적 방문
7303갱신 대기S–CData TierS/A/B차세대→Insight1032HER2 breast4683Antibody2713CGT→Psoriasis→NSCLC40FDA 승인
피드Data Tier차세대Insight

추천 비교

비교 도구 →
HER2 ADCEnhertu · Kadcyla · RC48CD19 CAR-TYescarta · KymriahPD-1Keytruda · Opdivo다발골수종Darzalex · BlenrepTROP2 ADCTrodelvy · Dato-DXd · SGNectin-4 · TROP2Padcev · Trodelvy건선 IL pathwayStelara · Cosentyx · SkyriziAnti-VEGF (안과)Eylea · LucentisAnti-TNFHumira · EnbrelIL-12/23Stelara · Skyrizi아토피·IL-13Dupixent · EbglyssPCSK9 · LDLRepatha · Praluent · LeqvioGLP-1 · incretinSemaglutide · Tirzepatide혈우병 유전자치료Hemgenix · Roctavian겸상적혈구 CGTCasgevy · Lyfgenia망막·DMD 유전자치료Luxturna · Elevidys

빠른 검색 · 이슈 태그

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 3,526개
다음 갱신 D-5 · 마지막 7월 21일
AntibodystaleRochePhase 3

Lenalidomide and rituximab (R2, Lenalidomide and rituximab, Lenalidomide and rituximab (R2) in 28-day cycles for up to 12 cycles.)

Follicular Lymphoma (FL) · Follicular Lymphoma (FL)

#FollicularLymphomaFL#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleBristol Myers SquibbPhase 2

nivolumab (Opdivo, N-803 + Nivolumab + PD-L1 t-haNK)

Non-Small Cell Lung Cancer; Small Cell Lung Cancer · PD-L1

#PD-L1#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
ADCBiologicstaleBliss Biopharmaceutical (Hangzh…Phase 1

BB-1705 (BB-1705)

Solid Tumor · Solid Tumor

#SolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleAmgenPhase 1

AMG 595 (AMG 595)

Advanced Malignant Glioma; Anaplastic Astrocytomas · Advanced Malignant Glioma

#AdvancedMalignantGlioma#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 ACTIVE
ADCBiologicstaleMabwell (Shanghai) Bioscience C…Phase 1

bulumtatug fuvedotin (bulumtatug fuvedotin)

Triple Negative Breast Cancer · Triple Negative Breast Cancer

#TripleNegativeBreastCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleMultitude Therapeutics Inc.Phase 1

AMT-151 (AMT-151)

Advanced Solid Tumor; Advanced Cancer · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 ACTIVE
ADCBiologicstaleCelldex TherapeuticsPhase 1

CDX-014 (CDX-014)

Renal Cell Carcinoma (RCC); Clear-cell Renal Cell Carcinoma · Renal Cell Carcinoma (RCC)

#RenalCellCarcinomaRCC#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 DISCONTINUED
ADCBiologicstaleBorstkanker Onderzoek GroepPhase 2

PTC-Pz (PTC-Pz)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleAlentis Therapeutics AGPhase 2

ALE.P02 (ALE.P02)

Squamous Non-small-cell Lung Cancer; Head and Neck Squamous Cell Carcinoma · Squamous Non-small-cell Lung Cancer

#SquamousNon-small-cellLungCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleShanghai Miracogen Inc.Phase 2

MRG002+HX008 (MRG002+HX008)

Advanced Malignant Solid Tumors · Advanced Malignant Solid Tumors

#AdvancedMalignantSolidTumors#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 ACTIVE
ADCBiologicstaleAstraZenecaPhase 2

AZD4360 (AZD4360)

Gastric Cancer; Gastroesophageal Junction Cancer · Gastric Cancer

#GastricCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
AntibodystaleEli LillyPhase 2

Capecitabine, Cetuximab, Oxaliplatin (Capecitabine, Cetuximab, Oxaliplatin)

Rectal Cancer · Rectal Cancer

#RectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 1

bevacizumab, reference product (Avastin®, Avastin® (bevacizumab, reference product))

Metastatic Colorectal Cancer (mCRC) · Metastatic Colorectal Cancer (mCRC)

#MetastaticColorectalCancermCRC#Antibody#Phase1#항체#면역항체+2
효능 ORR 5%임상시험 1상태 ACTIVE
ADCBiologicstaleLigaChem Biosciences, Inc.Phase 2

LCB84 (LCB84)

Advanced Solid Tumors · Advanced Solid Tumors

#AdvancedSolidTumors#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleFudan UniversityPhase 2

A1: SHR-A1811 (A1: SHR-A1811)

Triple-negative Breast Cancer · Triple-negative Breast Cancer

#Triple-negativeBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleEisai Inc.Phase 2

BB-1701 (BB-1701)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 ACTIVE
ADCBiologicstaleFudan UniversityPhase 2

B2: TROP2 ADC with Camrelizumab (B2: TROP2 ADC with Camrelizumab)

Triple-negative Breast Cancer · TROP2

#TROP2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleFudan UniversityPhase 2

C1: SHR-A1811 (C1: SHR-A1811)

Triple-negative Breast Cancer · Triple-negative Breast Cancer

#Triple-negativeBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleFudan UniversityPhase 2

C2: SHR-A1811 with BP102 (C2: SHR-A1811 with BP102)

Triple-negative Breast Cancer · Triple-negative Breast Cancer

#Triple-negativeBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleFudan UniversityPhase 2

D2: TROP2 ADC with BP102 (D2: TROP2 ADC with BP102)

Triple-negative Breast Cancer · TROP2

#TROP2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleFudan UniversityPhase 2

E1: SHR-A1811 (E1: SHR-A1811)

Triple-negative Breast Cancer · Triple-negative Breast Cancer

#Triple-negativeBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 3

Serplulimab combined with bevacizumab and first-line chemotherapy (Serplulimab combined with bevacizumab and first-line chemotherapy)

Non-small Cell Lung Cancer Stage II; Bevacizumab · Non-small Cell Lung Cancer Stage II

#Non-smallCellLungCancerStageII#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 ACTIVE
ADCBiologicstaleZymeworks BC Inc.Phase 1

ZW171 (ZW171)

Mesothelin-expressing Advanced Cancers · Mesothelin-expressing Advanced Cancers

#Mesothelin-expressingAdvancedCan#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 DISCONTINUED
ADCBiologicstaleEMD Serono Research & Developme…Phase 1

M1231 (M1231)

Metastatic Solid Tumors; Esophageal Cancer · Metastatic Solid Tumors

#MetastaticSolidTumors#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 ACTIVE
ADCBiologicstaleNovartis PharmaceuticalsPhase 1

LOP628 (LOP628)

cKIT-positive Solid Tumors; AML · cKIT-positive Solid Tumors

#cKIT-positiveSolidTumors#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 DISCONTINUED

92 / 142 페이지

← 이전다음 →
전체 8,428개 프로그램 보기